Deutsche Bank Ag\ Tg Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 104,748 shares of TGTX stock, worth $3.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,748

Previous 87,386 19.87%

Holding current value

$3.09 Million

Previous $1.55 Million 57.66%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.21 - $25.28 $298,800 - $438,911	17,362 Added 19.87%	104,748 $2.45 Million
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $103,869 - $149,643	-7,798 Reduced 8.19%	87,386 $1.55 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $39,411 - $64,475	3,027 Added 3.28%	95,184 $1.45 Million
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $9,218 - $25,957	-1,380 Reduced 1.48%	92,157 $1.57 Million
Q3 2023 Nov 09, 2023	SELL	$8.36 - $26.5 $20,155 - $63,891	-2,411 Reduced 2.51%	93,537 $781,000
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $455,359 - $1.03 Million	-29,416 Reduced 23.46%	95,948 $2.38 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $257,264 - $486,362	25,148 Added 25.09%	125,364 $1.89 Million
Q4 2022 Feb 13, 2023	BUY	$5.01 - $11.83 $33,005 - $77,936	6,588 Added 7.04%	100,216 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $12,722 - $23,385	-2,784 Reduced 2.89%	93,628 $554,000
Q2 2022 Aug 11, 2022	BUY	$3.74 - $10.66 $57,801 - $164,750	15,455 Added 19.09%	96,412 $409,000
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $672,706 - $1.76 Million	-86,134 Reduced 51.55%	80,957 $770,000
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $39,079 - $91,296	-2,571 Reduced 1.52%	167,091 $3.18 Million
Q3 2021 Nov 04, 2021	BUY	$21.78 - $40.45 $96,572 - $179,355	4,434 Added 2.68%	169,662 $5.65 Million
Q2 2021 Aug 11, 2021	BUY	$32.5 - $48.96 $41,015 - $61,787	1,262 Added 0.77%	165,228 $6.41 Million
Q1 2021 May 13, 2021	BUY	$41.61 - $54.3 $2.03 Million - $2.66 Million	48,896 Added 42.49%	163,966 $7.9 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $909,720 - $1.98 Million	36,000 Added 45.53%	115,070 $5.99 Million
Q3 2020 Nov 12, 2020	BUY	$18.49 - $27.24 $244,604 - $360,357	13,229 Added 20.09%	79,070 $2.12 Million
Q2 2020 Aug 13, 2020	SELL	$8.9 - $21.84 $244,402 - $599,748	-27,461 Reduced 29.43%	65,841 $1.28 Million
Q1 2020 May 14, 2020	SELL	$7.14 - $15.99 $41,504 - $92,949	-5,813 Reduced 5.86%	93,302 $919,000
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $119,783 - $263,054	-23,487 Reduced 19.16%	99,115 $1.1 Million
Q3 2019 Nov 14, 2019	SELL	$5.38 - $8.99 $5,159 - $8,621	-959 Reduced 0.78%	122,602 $687,000
Q2 2019 Aug 14, 2019	BUY	$6.27 - $8.65 $364,418 - $502,746	58,121 Added 88.82%	123,561 $1.07 Million
Q1 2019 May 15, 2019	SELL	$4.02 - $8.04 $3.05 Million - $6.1 Million	-758,724 Reduced 92.06%	65,440 $525,000
Q4 2018 Feb 14, 2019	BUY	$3.44 - $5.76 $500,361 - $837,815	145,454 Added 21.43%	824,164 $3.38 Million
Q3 2018 Dec 21, 2021	BUY	$5.15 - $14.0 $1.03 Million - $2.8 Million	200,023 Added 41.79%	678,710 $3.8 Million
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $1.86 Million - $5.06 Million	361,153 Added 307.28%	478,687 $2.68 Million
Q2 2018 Apr 21, 2020	BUY	$12.5 - $15.0 $292,037 - $350,445	23,363 Added 24.81%	117,534 $1.55 Million
Q2 2018 Aug 14, 2018	SELL	$12.5 - $15.0 $1.15 Million - $1.37 Million	-91,627 Reduced 49.32%	94,171 $1.24 Million
Q1 2018 Oct 18, 2019	BUY	$8.7 - $16.8 $1.13 Million - $2.18 Million	129,546 Added 230.3%	185,798 $2.64 Million
Q1 2018 May 15, 2018	SELL	$8.7 - $16.8 $537,120 - $1.04 Million	-61,738 Reduced 52.32%	56,252 $797,000
Q4 2017 Feb 14, 2018	BUY	$7.35 - $12.3 $394,577 - $660,313	53,684 Added 83.48%	117,990 $965,000
Q3 2017 Nov 14, 2017	BUY	$10.0 - $12.7 $643,060 - $816,686	64,306	64,306 $761,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account